Abstract

Hyperhomocysteinemia (hHcy) is regarded as an independent and strong risk factor for cerebrovascular diseases, stroke, and dementias. The hippocampus has a crucial role in spatial navigation and memory processes and is being constantly studied for neurodegenerative disorders. We used a moderate methionine (Met) diet at a dose of 2 g/kg of animal weight/day in duration of four weeks to induce mild hHcy in adult male Wistar rats. A novel approach has been used to explore the hippocampal metabolic changes using proton magnetic resonance spectroscopy (1H MRS), involving a 7T MR scanner in combination with histochemical and immunofluorescence analysis. We found alterations in the metabolic profile, as well as remarkable histo-morphological changes such as an increase of hippocampal volume, alterations in number and morphology of astrocytes, neurons, and their processes in the selective vulnerable brain area of animals treated with a Met-enriched diet. Results of both methodologies suggest that the mild hHcy induced by Met-enriched diet alters volume, histo-morphological pattern, and metabolic profile of hippocampal brain area, which might eventually endorse the neurodegenerative processes.

Highlights

  • Several nutritional factors can influence the risk of development of neurodegenerative diseases and their rate of progression

  • We measured total N-Acetyl Aspartate, myo-Inositol, total choline and total creatine containing compounds which were expressed as following ratios: tNAA/tCr, mIns/tNAA, mlns/tCr, tCho/tNAA and tCho/tCr

  • Quantification of 1H MRS in the hippocampus of animals showed tNAA to tCr, mIns/tNAA and mlns/tCr ratios in Met-enriched diet group (MDG) group compared to the control

Read more

Summary

Introduction

Several nutritional factors can influence the risk of development of neurodegenerative diseases and their rate of progression. Its elevated level in plasma, hyperhomocysteinemia (hHcy), is one of the known risk factors for cardioand cerebrovascular disorders. Development of the neurodegenerative disorders, such as progressive atherosclerosis and acute ischemic stroke, cognitive impairment, dementia, or Alzheimer’s disease (AD), is associated with hHcy [3,4,6], but the exact mechanism of its involvement in affecting neuronal tissue is not yet elucidated. S-adenosyl homocysteine (SAH), an intermediate of metabolic conversion of Hcy, was shown to be a metabolic sensor controlling methylation-regulated signalling within the Met-Hcy cycle. As a consequence, it potentially initiates the DNA and protein hypomethylation with an impact on diverse tissue disturbances, including neuronal cells [9]. The selective cytosolic and nuclear Hcy clearance is essential for cellular genetic protection

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.